Journal
BLOOD
Volume 104, Issue 4, Pages 1075-1082Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2003-06-1937
Keywords
-
Categories
Funding
- NCI NIH HHS [CA18029] Funding Source: Medline
- NIAID NIH HHS [AI53193, AI41754] Funding Source: Medline
Ask authors/readers for more resources
Although cytomegalovirus (CMV) expresses proteins that interfere with antigen presentation by class I major histocompatibility complex (MHC) molecules, CD8(+) cytotoxic T cells (CTLs) are indispensable for controlling infection and maintaining latency. Here, a cytokine flow cytometry assay that employs fibroblasts infected with a mutant strain of CMV (RV798), which is deleted of the 4 viral genes that are responsible for interfering with class I MHC presentation, was used to examine the frequency and specificity of the CD8(+) CTLs to CMV in immunocompetent CMV-seropositive individuals. A large fraction of the CD8(+) CTL response was found to be specific for viral antigens expressed during the immediate early and early phases of virus replication and presented by fibroblasts infected with RV798 but not wild-type CMV. These results demonstrate that the inhibition of class I antigen presentation observed in CMV-infected cells in vitro is not sufficient to prevent the induction of a broad repertoire of CD8(+) CTLs after natural infection in vivo. Thus, reconstitution of T-cell immunity in immunodeficient patients by cell therapy or by vaccination may need to target multiple viral antigens to completely restore immunologic control of CMV. (C) 2004 by The American Society of Hematology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available